A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer

NCT00102895 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
25
Enrollment
INDUSTRY
Sponsor class

Stopped See Detailed Description

Conditions

Interventions

Sponsor

Pfizer